Danaher Corporation (VIE:DHRC)

Austria flag Austria · Delayed Price · Currency is EUR
190.70
+2.40 (1.27%)
At close: Oct 23, 2025
1.27%
Market Cap132.83B
Revenue (ttm)20.75B
Net Income (ttm)3.00B
Shares Outn/a
EPS (ttm)4.16
PE Ratio44.34
Forward PE26.73
Dividend1.10 (0.58%)
Ex-Dividend DateSep 26, 2025
Volumen/a
Average Volume23
Open188.90
Previous Close188.30
Day's Range188.42 - 190.70
52-Week Range153.52 - 247.05
Betan/a
RSI66.38
Earnings DateOct 21, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man... [Read more]

Industry Laboratory Analytical Instruments
Founded 1969
Employees 63,000
Stock Exchange Vienna Stock Exchange
Ticker Symbol DHRC
Full Company Profile

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD Financial Statements

News

There is no news available yet.